Philip Aagaard
Albert Einstein College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Philip Aagaard.
Expert Review of Medical Devices | 2015
Philip Aagaard; Andrea Natale; Luigi Di Biase
Manual radio frequency (RF) ablation to restore a normal cardiac rhythm requires significant skill, manual dexterity and experience. In response to this, ablation methods and technologies have evolved rapidly in the past decade, including the development of remote navigation technologies. Today, two principal methods of remote navigation are available. One utilizes magnetic field vectors to navigate proprietary catheters, the other maneuvers standard catheters robotically. The main advantages of remote navigation include improved catheter stability, reduced fluoroscopy times and decreased total radiation exposure to both the patient and the operator. The main limitations include cost and longer procedure times. Remote magnetic navigation appears to have the best safety profile; however, its efficacy in creating lesions may be lower, which has been attributed to the soft-tip catheter used. Remote robotic navigation on the other hand, which uses regular catheter tips, is associated with a slightly higher overall complication rate, but higher efficacy. This article reviews the pros and cons of remote navigation for ablation of both atrial and ventricular substrates. Finally, it attempts to predict the direction of this field in the coming years.
Heart Failure Clinics | 2015
Philip Aagaard; Luigi Di Biase; Andrea Natale
HF and AF are on the rise and often coexist. Pharmacologic rhythm control has not been shown to improve outcomes compared with pharmacologic rate control. It is possible that the benefits of maintaining SR are offset by the adverse effects of AADs. Catheter ablation of AF offers an opportunity to achieve SR without the downside of AADs. Several studies have shown that AF ablation improves prognostic markers, including ventricular function, exercise tolerance, and perceived quality of life in HF patients. Studies addressing the impact of this treatment strategy on cardiovascular outcomes and cost-effectiveness are ongoing.
Journal of the American College of Cardiology | 2015
Faraj Kargoli; Eric Shulman; Philip Aagaard; Ethan Hoch; Luigi Di Biase; Kevin J. Ferrick; Andrew Krumerman
Lower socioeconomic status (SES) is associated with a higher risk of cardiovascular disease. However, the association of SES and survival in patients with atrial fibrillation (AF) is not clear. We examined whether SES predicts all-cause mortality in patients hospitalized with AF. This is a
Cardiology Clinics | 2016
Philip Aagaard; David F. Briceno; Zoltán Csanádi; Sanghamitra Mohanty; Carola Gianni; Chintan Trivedi; Edina Nagy-Baló; Stephan B. Danik; Conor D. Barrett; Francesco Santoro; J. David Burkhardt; Javier Sanchez; Andrea Natale; Luigi Di Biase
Catheter ablation has become a widely available and accepted treatment to restore sinus rhythm in atrial fibrillation patients who fail antiarrhythmic drug therapy. Although generally safe, the procedure carries a non-negligible risk of complications, including periprocedural cerebral insults. Uninterrupted anticoagulation, maintenance of an adequate ACT during the procedure, and measures to avoid and detect thrombus build-up on sheaths and atheters during the procedure, appears useful to reduce the risk of embolic events. This is a review of the incidence, mechanisms, impact, and methods to reduce catheter ablation related cerebral insults.
Journal of the American College of Cardiology | 2015
David F. Briceno; Pedro Villablanca Spinetto; Nicole Cyrille; Daniele Massera; Eric Bader; Eric Manheimer; Philip Aagaard; Kevin J. Ferrick; Jay N. Gross; Soo G. Kim; Andrew Krumerman; Eugen C. Palma; Nils Guttenplan; John D. Fisher; Mario J. Garcia; Andrea Natale; Luigi Di Biase
Different strategies have been evaluated for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). We sought to evaluate the efficacy and safety of different approaches compared to standard therapy with warfarin. We conducted electronic database searches of phase III
American Journal of Cardiology | 2014
Philip Aagaard; Eric Shulman; Luigi Di Biase; John D. Fisher; Jay N. Gross; Faraj Kargoli; Soo G. Kim; Eugen C. Palma; Kevin J. Ferrick; Andrew Krumerman
American Journal of Cardiology | 2017
Faraj Kargoli; Eric Shulman; Philip Aagaard; David F. Briceno; Ethan Hoch; Luigi Di Biase; John D. Fisher; Jay N. Gross; Soo G. Kim; Andrew Krumerman; Kevin J. Ferrick
Journal of the American College of Cardiology | 2018
Philip Aagaard; Shishir Sharma; David McNamara; Elizabeth Hill; Colby R. Ayers; James L. Gentry; Andrew E. Lincoln; Alexander Kezia; Reginald E. Dunn; Andrew M. Tucker; Parag H. Joshi; Dermot Phelan
Cardiac Electrophysiology: From Cell to Bedside (Seventh Edition) | 2018
Luigi Di Biase; Philip Aagaard; Pasquale Santangeli; Andrea Natale
/data/revues/00029149/unassign/S0002914915020834/ | 2015
Eric Shulman; Faraj Kargoli; Philip Aagaard; Ethan Hoch; Luigi Di Biase; John D. Fisher; Jay N. Gross; Soo G. Kim; Andrew Krumerman; Kevin J. Ferrick